Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer.

J Clin Oncol · 2020 · PMC7392741 · PMID 32459597

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

When analyzed by treatment phase, average global health status and physical functioning scores remained mostly similar during induction ( Fig 2B ), and physical functioning showed a trend toward improvement during maintenance ( Fig 2C ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.